All
1.
Structural and cognitive deficits in chronic carbon monoxide intoxication: a voxel-based morphometry study
Hsiu-Ling Chen, Pei-Chin Chen, Cheng-Hsien Lu, Nai-Wen Hsu, Kun-Hsien Chou, Ching-Po Lin, Re-Wen Wu, Shau-Hsuan Li, Yu-Fan Cheng, Wei-Che Lin BMC Neurology 2013, 13 :129 (1 October 2013)
Abstract | Provisional PDF
2.
Incidence and prevalence of multiple sclerosis in Europe: a systematic review
Elaine Kingwell, James J Marriott, Nathalie Jetté, Tamara Pringsheim, Naila Makhani, Sarah A Morrow, John D Fisk, Charity Evans, Sarah Gabrielle Béland, Sophie Kulaga, Jonathan Dykeman, Christina Wolfson, Marcus W Koch, Ruth Ann Marrie BMC Neurology 2013, 13 :128 (26 September 2013)
Abstract | Provisional PDF
| PubMed
3.
The multiple sclerosis relapse experience: patient-reported outcomes from the North American Research Committee on Multiple Sclerosis (NARCOMS) Registry
Molly Nickerson, Ruth Marrie BMC Neurology 2013, 13 :119 (10 September 2013)
Abstract | Full text | PDF
| ePUB | PubMed
4.
Evaluation of an electronic diary for improvement of adherence to interferon beta-1b in patients with multiple sclerosis: design and baseline results of an observational cohort study
Uwe K Zettl, Ulrike Bauer-Steinhusen, Thomas Glaser, Klaus Hechenbichler, Volker Limmroth, for the Study Group BMC Neurology 2013, 13 :117 (6 September 2013)
Abstract | Full text | PDF
| PubMed
5.
Endogenous retroviruses and multiple sclerosis–new pieces to the puzzle
Kari K Nissen, Magdalena J Laska, Bettina Hansen, Thorkild Terkelsen, Palle Villesen, Shervin Bahrami, Thor Petersen, Finn S Pedersen, Bjørn A Nexø BMC Neurology 2013, 13 :111 (28 August 2013)
Abstract | Full text | PDF
| ePUB | PubMed
6.
Passively transferred human NMO-IgG exacerbates demyelination in mouse experimental autoimmune encephalomyelitis
Harleen Saini, Robert Rifkin, Michael Gorelik, Hwa Huang, Zachary Ferguson, Melina V Jones, Michael Levy BMC Neurology 2013, 13 :104 (8 August 2013)
Abstract | Full text | PDF
| ePUB | PubMed
7.
Interferon beta 1b following natalizumab discontinuation: one year, randomized, prospective, pilot trial
Claudio Gobbi, Dominik S Meier, François Cotton, Martina Sintzel, David Leppert, Charles R G Guttmann, Chiara Zecca BMC Neurology 2013, 13 :101 (2 August 2013)
Abstract | Full text | PDF
| ePUB | PubMed
8.
Cognitive impairment and “invisible symptoms” are not associated with CCSVI in MS
Carmela Leone, Emanuele D’Amico, Sabina Cilia, Alessandra Nicoletti, Luigi Di Pino, Francesco Patti BMC Neurology 2013, 13 :97 (27 July 2013)
Abstract | Full text | PDF
| ePUB | PubMed
9.
Is a hypothetical melanoma-like neuromelanin the underlying factor essential for the aetiopathogenesis and clinical manifestations of multiple sclerosis?
Bernd Krone, John M Grange BMC Neurology 2013, 13 :91 (18 July 2013)
Abstract | Full text | PDF
| PubMed
10.
Small internal jugular veins with restricted outflow are associated with severe multiple sclerosis: a sonographer-blinded, case–control ultrasound study
Željko Krsmanović, Maja Živković, Toplica Lepić, Aleksandra Stanković, Ranko Raičević, Evica Dinčić BMC Neurology 2013, 13 :90 (17 July 2013)
Abstract | Full text | PDF
| ePUB | PubMed
